Mean Arterial Pressure (MAP) and Renal Perfusion: Evaluation of Critically Ill Patients With Normal Creatinine or Reduced Renal Function

MAP and Renal Perfusion: Evaluation of Critically Ill Patients With Normal Creatinine or Reduced Renal Function

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00117416

Enrollment

Registered

2005-07-06

Start date

2003-02-28

Completion date

2003-02-28

Last updated

2022-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Failure, Acute

Brief summary

The purpose of this study is to evaluate the renal perfusion depending on the MAP.

Interventions

PROCEDUREcontrolling the MAP

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Over 18 years old * Intensive care patient * Treated with vasopressor * Given informed consent * Arterial infusion * A bladder catheter

Exclusion criteria

* Anamneses of hypertension * Neurological trauma * Acute renal insufficiency other than prerenal or acute tubular necrosis etiology * Hepatorenal syndrome * Treated with diuretics * Mechanical ventilation and unstable

Design outcomes

Primary

Measure	Time frame
creatinine clearance after 4 hours	—

Secondary

Measure	Time frame
resistance index	—
diuresis	—
urinary indices of renal function	—

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026